Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.2084
Recommendation HOLD
P/E 18.54
ROE 11.63 %
Capitalization 2,080,080,000 $
Dividend Yield 0.00 %
P/S 2.69
AII Position 411
P/E Position 241
ROE Position 322
Capitalization Position 633
Dividend Yield Position 592
Sales 772,600,000 $
10-Year Average Earnings 112,174,300 $
Shares Outstanding 72,000,000
Equity 964,900,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2018 6 772,600,000.00 $
2017 6 769,900,000.00 $
2016 6 740,500,000.00 $
2015 6 722,500,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 6 131,100,000.00 $
2017 6 20,500,000.00 $
2016 6 117,200,000.00 $
2015 6 79,800,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 6 964,900,000.00 $
2017 6 768,000,000.00 $
2016 6 739,600,000.00 $
2015 6 661,700,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 6 72,000,000
2017 6 68,800,000
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:



Google News for MYRIAD GENETICS:

StreetInsider.com - 4 days ago
Myriad Genetics (MYGN) Says myPath Melanoma Test Receives ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the Medicare Administrative ...
iWatch Markets
Myriad Genetics, Inc. (NASDAQ:MYGN) Earnings Growth ...
Honing in on the valuation of Myriad Genetics, Inc. (NASDAQ:MYGN), we can take a look at several ratios. One of the quickest ways to ...
Find News
Rising above circumstances: Myriad Genetics, Inc. (MYGN), US ...
It's been an amazing ride for the share price of Myriad Genetics, Inc. (NASDAQ: MYGN) since the start of this year, with a year-to-date change of ...
FinBulletin
Myriad Genetics, Inc. (MYGN) Stock: Is There An Opportunity Here?
The social space is heating up with regard to Myriad Genetics, Inc. (MYGN). With so much interest, you could be wondering what's going on.
Zeeland Press - 8 hours ago
SMA 30 Hits 30.941 for Myriad Genetics, Inc. (NASDAQ:MYGN)
Myriad Genetics, Inc. (NASDAQ:MYGN) has drawn the attention of traders as the price has moved 0.1189768% since the open. The prior ...
Investing News Update
Myriad's myPath Melanoma Test Awarded Medicare Coverage
Myriad Genetics, Inc.MYGN recently announced the issuance of a final local coverage determination (LCD) by the Medicare Administrative ...
Voice Of Analysts
Can it sustain the pressure built by the Analysts: Myriad Genetics ...
[NASDAQ: MYGN]: On March 1st, 2019, Myriad Genetics (NASDAQ:MYGN) opened trading at $31.15 and closed at $30.84 a share. This is a ...
The Hi New Ulm
Myriad Genetics, Inc. (NasdaqGS:MYGN)'s Cash Flow Growth of ...
Myriad Genetics, Inc. (NasdaqGS:MYGN) has seen year over year cash flow change of -0.21759. This is calculated as the one year percentage ...
FinBulletin - 3 days ago
Myriad Genetics (MYGN) Reports Publication of Clinical Studies for ...
Myriad Genetics, Inc. (NASDAQ: MYGN) today announced the publication of an important clinical study regarding its Vectra® test in Current ...
iWatch Markets - 3 days ago
The Clues for capitalizing in these stocks: Weingarten Realty ...
For shares of Myriad Genetics, Inc. (NASDAQ: MYGN), there are currently ratings available from 10 different stock market analysts who have all ...


Back